Clinical Study

Randomized Phase II Trial Of Hypofractionated Dose-Escalated Photon Imrt Or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant And Adjuvant Temozolomide In Patients With Newly Diagnosed Glioblastoma

Posted Date: Jan 18, 2018

  • Investigator: Kevin Redmond
  • Co-Investigator: Nicky Kurtzweil
  • Specialties: Hematology/Oncology, Oncology, Cancer
  • Type of Study: Drug

The purpose of this study is to compare a different radiation therapy schedule and higher radiation dose to the standard dose of radiation therapy. All patients will receive usual chemotherapy, temozolomide. This study will allow researchers to know whether this higher dose is better, the same, or worse than the usual approach. To be better, the study should increase life by six months or more compared to the usual approach. Two methods of giving radiation therapy will also be compared. They are proton beam radiation and intensity-modulated radiation.


To Be Eligible For This Study, Patients Must Have A Brain Tumor Called Glioblastoma.


Tumor, Brain , Cancer, Glioblastoma, Nrg-Bn001

For More Information:

Uc Cancer Institute

  • Search Clinical Studies

  • Research in the News

    Enhanced Recovery Program for Colorectal Surgery Patients Reduces Costs

    A standardized protocol for managing patients for the duration of colorectaloperations not only improved clinical outcomes, but also it significantlyreduced hospital costs.